protein kinase, cGMP-dependent, type I | |
---|---|
![]()
Crystallographic structure of the leucine zipper domain of human cGMP dependent protein kinase I beta.
|
|
Identifiers | |
Symbol | PRKG1 |
Alt. symbols | PRKGR1B, PRKG1B |
Entrez | 5592 |
HUGO | 9414 |
OMIM | 176894 |
RefSeq | NM_006258 |
UniProt | Q13976 |
Other data | |
Locus | Chr. 10 q11.2 |
protein kinase, cGMP-dependent, type II | |
---|---|
Identifiers | |
Symbol | PRKG2 |
Entrez | 5593 |
HUGO | 9416 |
OMIM | 601591 |
RefSeq | NM_006259 |
UniProt | Q13237 |
Other data | |
Locus | Chr. 4 q13.1-21.1 |
cGMP-dependent protein kinase or Protein Kinase G (PKG) is a serine/threonine-specific protein kinase that is activated by cGMP. It phosphorylates a number of biologically important targets and is implicated in the regulation of smooth muscle relaxation, platelet function, sperm metabolism, cell division, and nucleic acid synthesis.
PKG are serine/threonine kinases that are present in a variety of eukaryotes ranging from the unicellular organism Paramecium to humans. Two PKG genes, coding for PKG type I (PKG-I) and type II (PKG-II), have been identified in mammals. The N-terminus of PKG-I is encoded by two alternatively spliced exons that specify for the PKG-Iα and PKG-Iβ isoforms. PKG-Iβ is activated at ~10-fold higher cGMP concentrations than PKG-Iα. The PKG-I and PKG-II are homodimers of two identical subunits (~75 kDa and ~85 kDa, respectively) and share common structural features.
Each subunit is composed of three functional domains:
Binding of cGMP to the regulatory domain induces a conformational change which stops the inhibition of the catalytic core by the N-terminus and allows the phosphorylation of substrate proteins. Whereas PKG-I is predominantly localized in the cytoplasm, PKG-II is anchored to the plasma membrane by N-terminal myristoylation.